Sakar Healthcare Limited (NSE:SAKAR)
518.40
-18.05 (-3.36%)
At close: Mar 27, 2026
Sakar Healthcare Employees
Sakar Healthcare had 342 employees as of March 31, 2025. The number of employees increased by 17 or 5.23% compared to the previous year.
Employees
342
Change (1Y)
17
Growth (1Y)
5.23%
Revenue / Employee
6.77M INR
Profits / Employee
737.46K INR
Market Cap
11.53B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 342 | 17 | 5.23% |
| Mar 31, 2024 | 325 | 28 | 9.43% |
| Mar 31, 2023 | 297 | 0 | - |
| Mar 31, 2022 | 297 | 50 | 20.24% |
| Mar 31, 2021 | 247 | 4 | 1.65% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Solara Active Pharma Sciences | 1,775 |
| Sigachi Industries | 1,507 |
| Jagsonpal Pharmaceuticals | 1,399 |
| Windlas Biotech | 1,346 |
| RPG Life Sciences | 1,331 |
| Ind-Swift Laboratories | 1,246 |
| Orchid Pharma | 736 |
Sakar Healthcare News
- 6 weeks ago - Sakar Healthcare Ltd (NSE:SAKAR) Q3 2026 Earnings Call Highlights: Impressive Revenue Growth ... - GuruFocus
- 6 weeks ago - Q3 2026 Sakar Healthcare Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Sakar Healthcare gets EMA approval to manufacture Imatinib for Accord’s European market - Business Upturn
- 5 months ago - Sakar Healthcare shares rise over 2.5% after securing nine new oncology product approvals across global markets - Business Upturn
- 5 months ago - Sakar Healthcare receives nine new marketing authorisations for Oncology products in EU and emerging markets - Business Upturn